MENU
APLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Apellis Pharmaceuticals (APLS) Earnings Date & Reports

A.I. Advisor
published Earnings

APLS is expected to report earnings to fall 20.87% to -36 cents per share on March 04

Apellis Pharmaceuticals APLS Stock Earnings Reports
Q4'24
Est.
$-0.36
Q3'24
Missed
by $0.17
Q2'24
Beat
by $0.01
Q1'24
Missed
by $0.07
Q4'23
Est.
$-0.73
The last earnings report on November 05 showed earnings per share of -46 cents, missing the estimate of -28 cents. With 412.06K shares outstanding, the current market capitalization sits at 3.64B.
View a ticker or compare two or three
APLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutics and drug delivery technologies to address chronic inflammatory diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Distributors
Address
100 Fifth Avenue
Phone
+1 617 977-5700
Employees
706
Web
https://www.apellis.com